Hemorrhoid, Lice Treatments Join Usual Suspects On FDA Import Alerts
This article was originally published in The Rose Sheet
"Detention without physical examination" alerts were ordered for the products because evidence exists that they are marketed or promoted as unapproved drugs to consumers in the US.
You may also be interested in...
In addition to postponing NDAC meeting on food handler antiseptic drug products, FDA is suspending most inspections of foreign manufacturing facilities through April. Latest consumer health industry conferences cancelled or postponed are Consumer Healthcare Product Association and Informa Markets events.
FDA places Kangdi Medical Devices on import alert and warns it on GMP violations initially noted in 2016. FDA also notes in warning that the Chinese company’s two pain-relief patches are noncompliant with the external analgesics TFM.
NAD advises Fit Products to modify FitTea claims because its formulation is not the same as studies submitted and reminds the firm that testimonials must not contain false claims about products.